HeadlinesBriefing favicon HeadlinesBriefing

Sector Investment 3 Days

×
8 articles summarized · Last updated: LATEST

Last updated: August 6, 2026, 8:30 AM ET

Infrastructure Fundraisings Surge

ECP successfully closed its largest fund to date, ECP VI, securing $8.1bn. This fundraise exceeded its target by more than 50% within an 18-month period. KKR also achieved a significant milestone, reaching a final close of $19.2bn for its latest flagship infrastructure fund. This amount marks KKR's largest fundraising effort to date, surpassing the $17bn gathered for its prior fund in March 2022. Agallas Equities is planning to launch its inaugural infrastructure fund, aiming for $5bn with a Caribbean focus. This new fund is targeting major projects in the Dominican Republic and the surrounding region, having already attracted initial interest from Gulf state family offices.

Asset Management and Sector Trends

Industriens Pension a Danish fund managing €37bn, continues to navigate geopolitical turbulence with a focus on its infrastructure strategy, co-investments, and secondaries. Head of infrastructure Mikkel Kjaersgaard stated that it remains "business as usual" for the fund despite current global uncertainties. Aware Super is on track to surpass A$250bn in assets under management following discussions for a merger with Prime Super. This potential merger would add Prime Super's approximately A$8bn in assets to Aware Super's considerably larger capital pool. Infrastructure remains a strong performer for KKR's real assets unit, while Nuveen's global heads of clean energy have departed. Kuwait has secured the largest foreign direct investment deal ever, valued at $16bn, underscoring significant activity in the sector. The debate continues on whether transport packaging assets should be considered a core part of the infrastructure class, with the ultimate decision resting with limited partners.

Healthcare Deal Activity

Altaris has announced its intention to acquire the Life Sciences & Healthcare business (LS&H) from Clarivate. This strategic acquisition marks a notable development in the healthcare and life sciences private equity space.